GPC3 and hemoglobin measurement: Simpson–Golabi–Behmel syndrome (SGBS) results from mutations in the Glypican 3 (GPC3) gene, disrupting the Wnt/β-catenin pathway and promoting uncontrolled cell growth, which increases the risk of HB [16].